AEHR Revenue Was Same as TRT Last Quarter
Aehr Test Systems (AEHR) reported quarterly revenue last night of $11 million vs. Trio-Tech International (TRT)’s revenue last quarter of $10.7 million.
They do exactly the same thing and have practically the same revenue, but TRT’s largest customer is AMD and TRT is poised for huge growth due to OpenAI.
Seems like TRT deserves a higher market cap than AEHR. TRT is NIA’s #2 favorite overall stock suggestion for 2026.
BTW, President Trump took equity stake this morning in Trilogy Metals (TMQ). We discussed Trilogy a few days ago it was founded by Contango ORE (CTGO) CEO Rick Van Nieuwenhuyse. Odds of Johnson Tract permitting are looking very good.
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from CTGO of US$30,000 cash for three months of coverage and could receive a total of up to US$80,000 cash for ten months of coverage. This message is meant for informational and educational purposes only and does not provide investment advice.
